Use of thiazole derivatives and analogues in the treatment of cancer

Details for Australian Patent Application No. 2006271375 (hide)

Owner Betagenon AB

Inventors Eriksson, Bjorn; Kurz, Guido; Westman, Jacob; Hedberg, Christian

Agent Griffith Hack

Pub. Number AU-A-2006271375

PCT Pub. Number WO2007/010273

Priority 0501721-5 21.07.05 SE; 60/595,620 21.07.05 US; 60/744,422 07.04.06 US

Filing date 21 July 2006

Wipo publication date 25 January 2007

International Classifications

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/010273 Priority application(s): WO2007/010273

14 February 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Jan 2008

10 June 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006271377-Novel epilepsy treatment

2006271370-Delta 6 desaturase from Thraustochytrid & its uses thereof